Tag: familialBreastCancer

Articles

• BRCA1 and BRCA2 mutation carriers
• Family history means higher risk and getting cancer at a younger age
• Protecting daughters from breast cancer — Teen years & young adulthood
• Protecting our daughters from BC — Prenatal period & infancy
• Protecting our daughters from breast cancer — Childhood and puberty
• Protecting our sons from breast cancer
• Screening mammograms should start at age 40

News

11/02/22

Women with a relative diagnosed by age 45 should consider early BC screening

09/10/21

Dietary polyphenols can counteract harmful BRCA mutations

12/02/20

Breast cancer risk increases at sister's age of diagnosis

12/03/17

Smoking increases breast cancer risk most when started young

01/23/17

Breast cancer in 2nd degree relatives can further increase risk

08/20/16

Virus related to mouse mammary tumor virus linked to breast cancer

03/15/15

Family history of prostate cancer linked to heightened BC risk

07/28/14

BC prognosis is inherited independent of tumor characteristics

02/09/14

Young birth control pill use heightens BC risk in BRCA1 carriers

03/25/13

Non-BRCA carriers in BRCA families may get BC at younger age

01/05/13

Those with family history at higher risk of BC in other breast

01/10/12

Father's breast cancer or BRCA mutation influences daughter's risk

12/27/11

Breast cancer in male and female relatives increases risk of BC

11/29/11

Teenage alcohol use increases BC risk for those with family history

11/11/11

Nigerian breast cancer patients have high rates of BRCA mutations

10/18/11

Previous appendectomy linked to cancer in Jewish BRCA carriers

10/10/11

BRCA carriers are diagnosed earlier than previous generation

06/26/11

Women inheriting BRCA mutations from fathers get BC at a younger age

06/04/11

Likelihood of death from breast cancer runs in families

05/30/11

Excessive weight gain during pregnancy not linked to BC in daughters

09/14/10

Does a family history of BC increase the risk of certain subtypes?

Studies

• Second Primary Breast Cancer in Young Breast Cancer Survivors Cite
  Brantley KD, Rosenberg SM, Collins LC, Ruddy KJ, Tamimi RM, Schapira L, et al. Second Primary Breast Cancer in Young Breast Cancer Survivors. JAMA Oncology. American Medical Association (AMA); 2024; 10.1001/jamaoncol.2024.0286
• BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization Cite
  Yerushalmi R, Pomerantz A, Lewin R, Paluch-Shimon S, Soussan-Gutman L, Baehner FL, et al. BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-024-07271-4
• The unique risk factor profile of triple negative breast cancer: a comprehensive meta-analysis Cite
  Kumar N, Ehsan S, Banerjee S, Fernandez Perez C, Lhuilier I, Neuner J, et al. The unique risk factor profile of triple negative breast cancer: a comprehensive meta-analysis. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2024; 10.1093/jnci/djae056
• Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer Cite
  Xiao Q, Mao X, Ploner A, Grassmann F, Rodriguez J, Eriksson M, et al. Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2024; 10.1093/jnci/djae030
• Abstract B083: The associations of breast density, hormone use, family history, reproductive and lifestyle factors with triple negative breast cancer: a systematic review and meta-analysis Cite
  Kumar N, Ehsan S, Banerjee S, Perez CF, Lhuilier I, Neuner J, et al. Abstract B083: The associations of breast density, hormone use, family history, reproductive and lifestyle factors with triple negative breast cancer: a systematic review and meta-analysis. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:B083-B083 10.1158/1538-7445.advbc23-b083
• Disparities in genetic testing for breast cancer among black and Hispanic women in the United States Cite
  Olufosoye O, Soler R, Babagbemi K. Disparities in genetic testing for breast cancer among black and Hispanic women in the United States. Clinical Imaging. Elsevier BV; 2023;:110066 10.1016/j.clinimag.2023.110066
• Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients Cite
  Vidarsdottir L, Olafsdottir EJ, Barkardottir RB, Bjarnadottir O, Jonasson JG, Sigurdsson S, et al. Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00600-8
• The interaction of diet, alcohol, genetic predisposition, and the risk of breast cancer: a cohort study from the UK Biobank Cite
  Zhu P, Zhang Y, Chen Q, Qiu W, Chen M, Xue L, et al. The interaction of diet, alcohol, genetic predisposition, and the risk of breast cancer: a cohort study from the UK Biobank. European Journal of Nutrition. Springer Science and Business Media LLC; 2023; 10.1007/s00394-023-03269-8
• Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics Cite
  Gamble LA, McClelland PH, Teke ME, Samaranayake SG, Juneau P, Famiglietti AL, et al. Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00585-4
• Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC) Cite
  Madrigal LF, Garcé MYR, Ruiz FJJ. Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC). Current Problems in Cancer. Elsevier BV; 2023;:101008 10.1016/j.currproblcancer.2023.101008
• Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA Cite
  Tuttle TM, Hui JYC. Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-14161-4
• Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer Cite
  Öfverholm A, Törngren T, Rosén A, Arver B, Einbeigi Z, Haraldsson K, et al. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer. Springer Science and Business Media LLC; 2023; 23 10.1186/s12885-023-11229-y
• Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: different biological and clinical entities with potentially diverse therapeutic opportunities Cite
  Zattarin E, Taglialatela I, Lobefaro R, Leporati R, Fucà G, Ligorio F, et al. Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: different biological and clinical entities with potentially diverse therapeutic opportunities. Critical Reviews in Oncology/Hematology. Elsevier BV; 2023;:104109 10.1016/j.critrevonc.2023.104109
• Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers Cite
  Wang Q, Zhang Y, Zeng E, Grassmann F, He W, Czene K. Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad104
• Risk Factors for Developing Both Primary Breast and Primary Ovarian Cancer: A Systematic Review Cite
  Ferris JS, Morgan DA, Tseng AS, Terry MB, Ottman R, Hur C, et al. Risk Factors for Developing Both Primary Breast and Primary Ovarian Cancer: A Systematic Review. Critical Reviews in Oncology/Hematology. Elsevier BV; 2023;:104081 10.1016/j.critrevonc.2023.104081
• Family history and breast cancer risk for Asian women: a systematic review and meta-analysis Cite
  Wang H, MacInnis RJ, Li S. Family history and breast cancer risk for Asian women: a systematic review and meta-analysis. BMC Medicine. Springer Science and Business Media LLC; 2023; 21 10.1186/s12916-023-02950-3
• Risk of ER-specific breast cancer by family history of ER subtypes and other cancers Cite
  Wang Q, Zhang Y, Zeng E, Grassmann F, He W, Czene K. Risk of ER-specific breast cancer by family history of ER subtypes and other cancers. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad104
• Prediction of breast cancer risk for sisters of women attending screening Cite
  Mao X, He W, Eriksson M, Lindström LS, Holowko N, Bajalica-Lagercrantz S, et al. Prediction of breast cancer risk for sisters of women attending screening. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2023; 10.1093/jnci/djad101
• Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study Cite
  Bucalo A, Conti G, Valentini V, Capalbo C, Bruselles A, Tartaglia M, et al. Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study. European Journal of Cancer. Elsevier BV; 2023; 188:183-191 10.1016/j.ejca.2023.04.022
• 181P Male breast cancer (MBC): Familial history (FH), clinicopathological (CP) characteristics, oncogenetic (OG) testing and outcome in a cohort of 98 patients (pts) Cite
  Chretien S, Aymes E, Barthoulot M, Deley ML, Boulaire M, Oca F, et al. 181P Male breast cancer (MBC): Familial history (FH), clinicopathological (CP) characteristics, oncogenetic (OG) testing and outcome in a cohort of 98 patients (pts). ESMO Open. Elsevier BV; 2023; 8:101458 10.1016/j.esmoop.2023.101458
• The association between age at breast cancer diagnosis and prevalence of pathogenic variants Cite
  Daly MB, Rosenthal E, Cummings S, Bernhisel R, Kidd J, Hughes E, et al. The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 199:617-626 10.1007/s10549-023-06946-8
• Familial aggregation of early‐onset cancers in early‐onset breast cancer families Cite
  Rantala JNJ, Heikkinen SMM, Hirvonen EM, Tanskanen T, Malila NK, Pitkäniemi JM. Familial aggregation of early‐onset cancers in early‐onset breast cancer families. International Journal of Cancer. Wiley; 2023; 10.1002/ijc.34538
• Abstract 988: Long-term health outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer Cite
  Hassan H, Rahman T, Bacon A, Knott C, Allen I, Huntley C, et al. Abstract 988: Long-term health outcomes of bilateral salpingo-oophorectomy in women with personal history of breast cancer. Cancer Research. American Association for Cancer Research (AACR); 2023; 83:988-988 10.1158/1538-7445.am2023-988
• Risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer: a single-institution 10-year experience Cite
  Nagashima M, Ishikawa T, Asami Y, Hirose Y, Shimada K, Miyagami S, et al. Risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer: a single-institution 10-year experience. Japanese Journal of Clinical Oncology. Oxford University Press (OUP); 2023; 10.1093/jjco/hyad020
• Prognostic and Predictive Biomarkers in Familial Breast Cancer Cite
  Deb S, Chakrabarti A, Fox SB. Prognostic and Predictive Biomarkers in Familial Breast Cancer. Cancers. MDPI AG; 2023; 15:1346 10.3390/cancers15041346
• Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers Cite
  Lewinsohn R, Zheng Y, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, et al. Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers. Clinical Breast Cancer. Elsevier BV; 2022; 10.1016/j.clbc.2022.12.012
• Genetic Predisposition to Male Breast Cancer: A Case Series Cite
  APESSOS A, AGIANNITOPOULOS K, PEPE G, TSAOUSIS GN, PITTA P, BILI C, et al. Genetic Predisposition to Male Breast Cancer: A Case Series. Anticancer Research. Anticancer Research USA Inc.; 2022; 42:5795-5801 10.21873/anticanres.16086
• Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis Cite
  Durham DD, Abraham LA, Roberts MC, Khan CP, Smith RA, Kerlikowske K, et al. Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis. Cancer. Wiley; 2022; 10.1002/cncr.34365
• High risk breast cancer screening is a double edged sword: A qualitative study of patient perspectives on the Ontario High Risk Breast Cancer Screening Program Cite
  Deng SX, Castelo M, Reel E, Naganathan G, Eisen A, Muradali D, et al. High risk breast cancer screening is a double edged sword: A qualitative study of patient perspectives on the Ontario High Risk Breast Cancer Screening Program. Clinical Breast Cancer. Elsevier BV; 2022; 10.1016/j.clbc.2022.08.004
• Family history of breast cancer, mammographic breast density and breast cancer risk: Findings from a cohort study of Korean women Cite
  Mai Tran TX, Kim S, Song H, Park B. Family history of breast cancer, mammographic breast density and breast cancer risk: Findings from a cohort study of Korean women. The Breast. Elsevier BV; 2022; 65:180-186 10.1016/j.breast.2022.08.008
• Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants Cite
  Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y, et al. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants. JAMA Oncology. American Medical Association (AMA); 2022; 8:871 10.1001/jamaoncol.2022.0476
• Molecular phenotypes and clinical characterization of familial hereditary breast cancer among half and full sisters Cite
  Xu Y, He J, Qian C, Yang C. Molecular phenotypes and clinical characterization of familial hereditary breast cancer among half and full sisters. BMC Women's Health. Springer Science and Business Media LLC; 2022; 22 10.1186/s12905-022-01732-y
• Metabolomics and the Multi-Omics View of Cancer Cite
  Wishart D. Metabolomics and the Multi-Omics View of Cancer. Metabolites. MDPI AG; 2022; 12:154 10.3390/metabo12020154
• Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland Cite
  Pallonen TA, Lempiäinen SMM, Joutsiniemi TK, Aaltonen RI, Pohjola PE, Kankuri-Tammilehto MK. Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland. Scientific Reports. Springer Science and Business Media LLC; 2022; 12 10.1038/s41598-022-10519-y
• Healthy lifestyle index and the risk of ductal carcinoma in situ of the breast in the Women's Health Initiative Cite
  Peila R, Lane DS, Shadyab AH, Saquib N, Strickler HD, Manson JE, et al. Healthy lifestyle index and the risk of ductal carcinoma in situ of the breast in the Women's Health Initiative. International Journal of Cancer. Wiley; 2022; 10.1002/ijc.34034
• Abstract P3-07-01: Young women with breast cancer and high risk family history but no high penetrance germline mutations have a higher load of rare high functional impact germline variants in cancer relevant genes Cite
  Rozenblit M, Qing T, Ye Y, Zhao H, Hofstatter E, Singh V, et al. Abstract P3-07-01: Young women with breast cancer and high risk family history but no high penetrance germline mutations have a higher load of rare high functional impact germline variants in cancer relevant genes. Cancer Research. American Association for Cancer Research (AACR); 2022; 82:P3-07-01-P3-07-01 10.1158/1538-7445.sabcs21-p3-07-01
• The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations Cite
  Tomiczek-Szwiec J, Szwiec M, Falco M, Cybulski C, Wokolorczyk D, Jakubowska A, et al. The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations. British Journal of Cancer. Springer Science and Business Media LLC; 2022; 10.1038/s41416-022-01770-1
• Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women Cite
  Han Y, Moore JX, Colditz GA, Toriola AT. Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women. JAMA Network Open. American Medical Association (AMA); 2022; 5:e2148983 10.1001/jamanetworkopen.2021.48983
• Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing Cite
  Southey MC, Dowty JG, Riaz M, Steen JA, Renault A, Tucker K, et al. Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00360-3
• Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes Cite
  Kurian AW, Abrahamse P, Ward KC, Hamilton AS, Deapen D, Berek JS, et al. Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes. JCO Precision Oncology. American Society of Clinical Oncology (ASCO); 2021;:1853-1859 10.1200/po.21.00261
• Early-life exposures and age at thelarche in the Sister Study cohort Cite
  Goldberg M, D’Aloisio AA, O’Brien KM, Zhao S, Sandler DP. Early-life exposures and age at thelarche in the Sister Study cohort. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01490-z
• Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study Cite
  Zheng G, Sundquist J, Sundquist K, Ji J. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-08925-y
• Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review Cite
  Daniele A, Divella R, Pilato B, Tommasi S, Pasanisi P, Patruno M, et al. Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review. Hereditary Cancer in Clinical Practice. Springer Science and Business Media LLC; 2021; 19 10.1186/s13053-021-00199-6
• Risk-Reducing Salpingo-oophorectomy (RRSO) Cite
  Kobayashi Y, Aoki D. Risk-Reducing Salpingo-oophorectomy (RRSO). Hereditary Breast and Ovarian Cancer. Springer Singapore; 2021;:183-191 10.1007/978-981-16-4521-1_12
• Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists Cite
  Ademuyiwa FO, Salyer P, Tao Y, Luo J, Hensing WL, Afolalu A, et al. Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021; 10.1200/jco.21.01426
• Penetrance of male breast cancer susceptibility genes: a systematic review Cite
  Chamseddine RS, Wang C, Yin K, Wang J, Singh P, Zhou J, et al. Penetrance of male breast cancer susceptibility genes: a systematic review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06413-2
• Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk Cite
  Gamble LA, Rossi A, Fasaye G, Kesserwan C, Hernandez JM, Blakely AM, et al. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. JAMA Surgery. American Medical Association (AMA); 2021; 10.1001/jamasurg.2021.5118
• Retrospective Analysis of Clinicopathological Features and Familial Cancer History of Synchronous Bilateral Breast Cancer Cite
  Huang K, Liu Y, Hsu Y, Kuo W. Retrospective Analysis of Clinicopathological Features and Familial Cancer History of Synchronous Bilateral Breast Cancer. Healthcare. MDPI AG; 2021; 9:1203 10.3390/healthcare9091203
• Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women Cite
  Evans DG, Howell SJ, Gandhi A, van Veen EM, Woodward ER, Harvey J, et al. Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06333-1
• Risk of Late-Onset Breast Cancer in Genetically Predisposed Women Cite
  Boddicker NJ, Hu C, Weitzel JN, Kraft P, Nathanson KL, Goldgar DE, et al. Risk of Late-Onset Breast Cancer in Genetically Predisposed Women. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021;:JCO.21.00531 10.1200/jco.21.00531
• Paternal High-Fat Diet Exposure Induces Adverse Effects on Offspring Health: a Systematic Review of Animal Studies Cite
  Gonçalves MdS, Perez GdS, Ferreira LdJD, Santos LSd, Cordeiro GdS, Couto RD, et al. Paternal High-Fat Diet Exposure Induces Adverse Effects on Offspring Health: a Systematic Review of Animal Studies. Brazilian Archives of Biology and Technology. FapUNIFESP (SciELO); 2021; 64 10.1590/1678-4324-2021190123
• Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer Cite
  Abubakar M, Guo C, Koka H, Zhu B, Deng J, Hu N, et al. Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06294-5
• Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer Cite
  Kim GR, Cho N, Kim S, Han W, Moon WK. Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer. Radiology. Radiological Society of North America (RSNA); 2021;:203074 10.1148/radiol.2021203074
• Male and female breast cancer: the two faces of the same genetic susceptibility coin Cite
  Silva SN, Gomes BC, André S, Félix A, Rodrigues AS, Rueff J. Male and female breast cancer: the two faces of the same genetic susceptibility coin. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06159-x
• Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History Cite
  van den Broek JJ, Schechter CB, van Ravesteyn NT, Janssens ACJW, Wolfson MC, Trentham-Dietz A, et al. Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2020; 113:434-442 10.1093/jnci/djaa127
• Risk factors for contralateral breast cancer in postmenopausal breast cancer survivors in the NIH-AARP Diet and Health Study Cite
  Ramin C, Mullooly M, Schonfeld SJ, Advani PG, Bodelon C, Gierach GL, et al. Risk factors for contralateral breast cancer in postmenopausal breast cancer survivors in the NIH-AARP Diet and Health Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2021; 10.1007/s10552-021-01432-2
• Heredity and Male Breast Cancer: A Series of 72 Men with Breast Cancer Cite
  Rodríguez-Fernández V, Cameselle-Cortizo L, García-Mallo A, Ortiz Elena M, Castro-Parga GJD, Figueiredo-Alonso E, et al. Heredity and Male Breast Cancer: A Series of 72 Men with Breast Cancer. International Journal of Medical Science and Health Research. International Journal of Medical Science and Health Research; 2021; 05:155-166 10.51505/ijmshr.2021.5213
• The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study Cite
  Sandvei MS, Opdahl S, Valla M, Lagiou P, Vesterfjell EV, Rise TV, et al. The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-08027-9
• Correlation between family history and characteristics of breast cancer Cite
  Liu L, Hao X, Song Z, Zhi X, Zhang S, Zhang J. Correlation between family history and characteristics of breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2021; 11 10.1038/s41598-021-85899-8
• Early-life risk factors for breast cancer - prospective follow-up in the Northern Finland Birth Cohort 1966 Cite
  Tastula A, Jukkola A, Alakokkare A, Nordström T, Eteläinen S, Karihtala P, et al. Early-life risk factors for breast cancer - prospective follow-up in the Northern Finland Birth Cohort 1966. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.1442.2020 10.1158/1055-9965.epi-20-1442
• Screening and Preventative Strategies for Patients at High Risk for Breast Cancer Cite
  Ter-Minassian M, Schaeffer ML, Jefferson CR, Shapiro SC, Suwannarat P, Visvanathan K. Screening and Preventative Strategies for Patients at High Risk for Breast Cancer. JCO Oncology Practice. American Society of Clinical Oncology (ASCO); 2021;:OP.20.00262 10.1200/op.20.00262
• Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers Cite
  Stjepanovic N, Lubinski J, Moller P, Randall Armel S, Foulkes WD, Tung N, et al. Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06072-9
• Relationship Between Proliferative Breast Lesions and Breast Cancer Risk Factors Cite
  Toktaş O, Elasan S, İliklerden ÜH, Erten R, Karayil AR, Özdemir A, et al. Relationship Between Proliferative Breast Lesions and Breast Cancer Risk Factors. European Journal of Breast Health. Galenos Yayinevi; 2021; 17:15-20 10.4274/ejbh.2020.5713
• Association between changes in mammographic density category and the risk of breast cancer: A nationwide cohort study in East‐Asian women Cite
  Kim S, Park B. Association between changes in mammographic density category and the risk of breast cancer: A nationwide cohort study in East‐Asian women. International Journal of Cancer. Wiley; 2020; 10.1002/ijc.33455
• Family history of breast cancer and risk of benign breast diseases: an integrative literature review Cite
  Schilling MPR, Silva IFd. Family history of breast cancer and risk of benign breast diseases: an integrative literature review. Mastology. Mastology; 2020; 30 10.29289/25945394202020200039
• Heritable Susceptibility to Breast Cancer among African-American Women in the Detroit Research on Cancer Survivors Study Cite
  Purrington KS, Raychaudhuri S, Simon MS, Clark J, Ratliff V, Dyson G, et al. Heritable Susceptibility to Breast Cancer among African-American Women in the Detroit Research on Cancer Survivors Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:2369-2375 10.1158/1055-9965.epi-20-0564
• Evidence for familial clustering in breast cancer age of onset Cite
  Von Holle A, O’Brien KM, Sandler DP, Weinberg CR. Evidence for familial clustering in breast cancer age of onset. International Journal of Epidemiology. Oxford University Press (OUP); 2020; 10.1093/ije/dyaa201
• Circulating carotenoids and breast cancer among high-risk individuals Cite
  Peng C, Gao C, Lu D, Rosner BA, Zeleznik O, Hankinson SE, et al. Circulating carotenoids and breast cancer among high-risk individuals. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2020; 10.1093/ajcn/nqaa316
• Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study Cite
  Mukama T, Fallah M, Brenner H, Xu X, Sundquist K, Sundquist J, et al. Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study. BMC Medicine. Springer Science and Business Media LLC; 2020; 18 10.1186/s12916-020-01772-x
• Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer Cite
  Lovejoy LA, Rummel SK, Turner CE, Shriver CD, Ellsworth RE. Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer. Familial Cancer. Springer Science and Business Media LLC; 2020; 10.1007/s10689-020-00213-1
• Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer Cite
  Sim EJ, Ko K, Ahn C, Park SM, Surh Y, An S, et al. Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 184:615-626 10.1007/s10549-020-05875-0
• Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients Cite
  Nizic-Kos T, Krajc M, Blatnik A, Stegel V, Skerl P, Novakovic S, et al. Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-09178-y
• The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids Cite
  Houghton LC, Howland RE, Wei Y, Ma X, Kehm RD, Chung WK, et al. The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 10.1158/1055-9965.epi-20-0471
• Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience Cite
  Bennett I, Tourani S, Cockburn L, Reasbeck J, Grobbelaar N, Dann S, et al. Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience. ANZ Journal of Surgery. Wiley; 2020; 10.1111/ans.16320
• Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling Cite
  Calip GS, Kidd J, Bernhisel R, Cox HC, Saam J, Rauscher GH, et al. Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05922-w
• The impact of selected risk factors among breast cancer molecular subtypes: a case-only study Cite
  Pizzato M, Carioli G, Rosso S, Zanetti R, La Vecchia C. The impact of selected risk factors among breast cancer molecular subtypes: a case-only study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 184:213-220 10.1007/s10549-020-05820-1
• Evidence for Increased Susceptibility to Breast Cancer From Exposure to Ionizing Radiation Due to a Familial History of Breast Cancer: Results From the Swedish Hemangioma Cohort Cite
  Eidemüller M, Holmberg E, Lundell M, Karlsson P. Evidence for Increased Susceptibility to Breast Cancer From Exposure to Ionizing Radiation Due to a Familial History of Breast Cancer: Results From the Swedish Hemangioma Cohort. American Journal of Epidemiology. Oxford University Press (OUP); 2020; 10.1093/aje/kwaa163
• Hereditary diffuse gastric cancer: updated clinical practice guidelines Cite
  Blair VR, McLeod M, Carneiro F, Coit DG, D'Addario JL, van Dieren JM, et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. The Lancet Oncology. Elsevier BV; 2020; 21:e386-e397 10.1016/s1470-2045(20)30219-9
• Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study Cite
  Luen S, Asher R, Lee C, Savas P, Kammler R, Dell’Orto P, et al. Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study. Annals of Oncology. Elsevier BV; 2020; 31:1359-1365 10.1016/j.annonc.2020.06.024
• Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations Cite
  Lambertini M, Ameye L, Hamy A, Zingarello A, Poorvu PD, Carrasco E, et al. Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:3012-3023 10.1200/jco.19.02399
• Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer Cite
  Collins JM, Isaacs C. Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer. The Breast Journal. Wiley; 2020; 26:1520-1527 10.1111/tbj.13970
• Hereditary and breastfeeding factors are positively associated with the aetiology of mammary gland hyperplasia: a case–control study Cite
  Gao H, Yang C, Fan J, Lan L, Pang D. Hereditary and breastfeeding factors are positively associated with the aetiology of mammary gland hyperplasia: a case–control study. International Health. Oxford University Press (OUP); 2020; 10.1093/inthealth/ihaa028
• Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review Cite
  Corso G, Montagna G, Figueiredo J, La Vecchia C, Fumagalli Romario U, Fernandes MS, et al. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review. Cancers. MDPI AG; 2020; 12:1598 10.3390/cancers12061598
• Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline Cite
  McGuire KP, Mamounas EP. Management of Hereditary Breast Cancer: ASCO, ASTRO, and SSO Guideline. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 27:1721-1723 10.1245/s10434-020-08396-8
• Abstract C035: Relationship between ancestry fractions and gene expression in triple-negative breast cancer in Hispanic/Latina women Cite
  Carrasquilla L, Garai J, Serrano-Gomez SJ, Sanabria-Salas MC, Baddoo MC, Fejerman L, et al. Abstract C035: Relationship between ancestry fractions and gene expression in triple-negative breast cancer in Hispanic/Latina women. Poster Presentations - Proffered Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7755.disp18-c035
• Abstract C052: Premenopausal oophorectomy and survival among women with breast cancer: Evidence of effect measure modification by family history status Cite
  Roberson ML, Robinson WR, Nichols HB, Olshan AF, Troester MA. Abstract C052: Premenopausal oophorectomy and survival among women with breast cancer: Evidence of effect measure modification by family history status. Poster Presentations - Proffered Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7755.disp18-c052
• Abstract D101: Breast cancer in Black women: Do risk factors differ for those who have a family history of breast cancer? Cite
  Zirpoli GR, Bethea TN, Bernstein L, Troester MA, Ambrosone CB, Palmer JR. Abstract D101: Breast cancer in Black women: Do risk factors differ for those who have a family history of breast cancer?. Poster Presentations - Proffered Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7755.disp19-d101
• Healthcare disparities and the demand for expanding hereditary breast cancer screening guidelines in African Americans. Cite
  Ciuro JA, Ahsan S, Beyer A, Jackson N. Healthcare disparities and the demand for expanding hereditary breast cancer screening guidelines in African Americans.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:e13636-e13636 10.1200/jco.2020.38.15_suppl.e13636
• Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history Cite
  Mukama T, Kharazmi E, Sundquist K, Sundquist J, Brenner H, Fallah M. Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history. Cancer. Wiley; 2020; 126:2837-2848 10.1002/cncr.32815
• Breast cancer survival following MRI detection in a high‐risk screening program Cite
  Hollingsworth AB, Pearce MR, Stough RG. Breast cancer survival following MRI detection in a high‐risk screening program. The Breast Journal. Wiley; 2020; 26:991-994 10.1111/tbj.13813
• Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience Cite
  Rummel SK, Lovejoy LA, Turner CE, Shriver CD, Ellsworth RE. Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience. Cancers. MDPI AG; 2020; 12:234 10.3390/cancers12010234
• Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank Cite
  Arthur RS, Wang T, Xue X, Kamensky V, Rohan TE. Genetic Factors, Adherence to Healthy Lifestyle Behavior, and Risk of Invasive Breast Cancer Among Women in the UK Biobank. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2020; 112:893-901 10.1093/jnci/djz241
• Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG) Cite
  Pal T, Agnese D, Daly M, La Spada A, Litton J, Wick M, et al. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. Springer Science and Business Media LLC; 2019; 22:681-685 10.1038/s41436-019-0712-x
• Reproductive and lifestyle factors related to breast cancer among Japanese women Cite
  Liu R, Kitamura Y, Kitamura T, Sobue T, Sado J, Sugawara Y, et al. Reproductive and lifestyle factors related to breast cancer among Japanese women. Medicine. Ovid Technologies (Wolters Kluwer Health); 2019; 98:e18315 10.1097/md.0000000000018315
• Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer Cite
  Zhang D, Nichols HB, Troester M, Cai J, Bensen JT, Sandler DP. Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer. International Journal of Cancer. Wiley; 2020; 147:876-886 10.1002/ijc.32824
• Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women Cite
  Bertrand KA, Bethea TN, Rosenberg L, Bandera EV, Khoury T, Troester MA, et al. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women. The Breast. Elsevier BV; 2020; 49:108-114 10.1016/j.breast.2019.10.009
• Breast cancer risk factors that are identical and differential associated with menopause status of women in Northeast Brazil Cite
  Gomes KAL, Jerônimo AFdA, Ramos RdO, Andrade LSdS, Weller M. Breast cancer risk factors that are identical and differential associated with menopause status of women in Northeast Brazil. Research Square; 2019; 10.21203/rs.2.14276/v1
• Interval breast cancer risk associations with breast density, family history and breast tissue aging Cite
  Nguyen TL, Li S, Dite GS, Aung YK, Evans CF, Trinh HN, et al. Interval breast cancer risk associations with breast density, family history and breast tissue aging. International Journal of Cancer. Wiley; 2019; 147:375-382 10.1002/ijc.32731
• Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk Cite
  Kehm RD, Genkinger JM, MacInnis RJ, John EM, Phillips K, Dite GS, et al. Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk. Cancer Research. American Association for Cancer Research (AACR); 2019; 80:116-125 10.1158/0008-5472.can-19-1847
• Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing Cite
  Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C, Mei B, et al. Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2019; 178:557-564 10.1007/s10549-019-05429-z
• Medication Use to Reduce Risk of Breast Cancer Cite
  Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, et al. Medication Use to Reduce Risk of Breast Cancer. JAMA. American Medical Association (AMA); 2019; 322:857 10.1001/jama.2019.11885
• Blood arsenic levels and the risk of familial breast cancer in Poland Cite
  Marciniak W, Derkacz R, Muszyńska M, Baszuk P, Gronwald J, Huzarski T, et al. Blood arsenic levels and the risk of familial breast cancer in Poland. International Journal of Cancer. Wiley; 2020; 146:2721-2727 10.1002/ijc.32595
• Predictors of mammographic density among women with a strong family history of breast cancer Cite
  Moran O, Eisen A, Demsky R, Blackmore K, Knight JA, Panchal S, et al. Predictors of mammographic density among women with a strong family history of breast cancer. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-5855-2
• Hereditary Breast Cancer: Prophylactic Mastectomy, Breast Conservation, and Rates of Cancer Cite
  Walsh SM, Robson ME, Sacchini VS. Hereditary Breast Cancer: Prophylactic Mastectomy, Breast Conservation, and Rates of Cancer. Oncoplastic and Reconstructive Breast Surgery. Springer International Publishing; 2019;:33-42 10.1007/978-3-319-62927-8_4
• Breast cancer histologic subtypes show excess familial clustering Cite
  Henry NL, Cannon‐Albright LA. Breast cancer histologic subtypes show excess familial clustering. Cancer. Wiley; 2019; 125:3131-3138 10.1002/cncr.32198
• Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study Cite
  Kehm RD, Hopper JL, John EM, Phillips K, MacInnis RJ, Dite GS, et al. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2019; 21 10.1186/s13058-019-1135-y
• Dietary index scores and invasive breast cancer risk among women with a family history of breast cancer Cite
  Petimar J, Park YM, Smith-Warner SA, Fung TT, Sandler DP. Dietary index scores and invasive breast cancer risk among women with a family history of breast cancer. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2019; 109:1393-1401 10.1093/ajcn/nqy392
• Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study Cite
  Touillaud M, Gelot A, Mesrine S, Bennetau-Pelissero C, Clavel-Chapelon F, Arveux P, et al. Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2019; 109:597-605 10.1093/ajcn/nqy313
• Abstract P4-10-08: Family history of breast cancer and mammographic density in premenopausal women Cite
  Han Y, Zong X, Colditz G, Toriola A. Abstract P4-10-08: Family history of breast cancer and mammographic density in premenopausal women. Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p4-10-08
• 10-year performance of four models of breast cancer risk: a validation study Cite
  Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, et al. 10-year performance of four models of breast cancer risk: a validation study. The Lancet Oncology. Elsevier BV; 2019; 20:504-517 10.1016/s1470-2045(18)30902-1
• The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans Cite
  Kim H, Choi DH, Park W, Im Y, Ahn JS, Park YH, et al. The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans. Hereditary Cancer in Clinical Practice. Springer Science and Business Media LLC; 2019; 17 10.1186/s13053-018-0103-3
• Women’s occupational exposure to polycyclic aromatic hydrocarbons and risk of breast cancer Cite
  Lee DG, Burstyn I, Lai AS, Grundy A, Friesen MC, Aronson KJ, et al. Women’s occupational exposure to polycyclic aromatic hydrocarbons and risk of breast cancer. Occupational and Environmental Medicine. BMJ; 2018; 76:22-29 10.1136/oemed-2018-105261
• Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study Cite
  Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2018; 111:350-364 10.1093/jnci/djy132
• Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women Cite
  Yoon TI, Kwak BS, Yi OV, Kim S, Um E, Yun KW, et al. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 173:657-665 10.1007/s10549-018-5031-4
• Adult Physical Activity and Breast Cancer Risk in Women with a Family History of Breast Cancer Cite
  Niehoff NM, Nichols HB, Zhao S, White AJ, Sandler DP. Adult Physical Activity and Breast Cancer Risk in Women with a Family History of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2018; 28:51-58 10.1158/1055-9965.epi-18-0674
• Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study Cite
  Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, et al. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:1513-1520 10.1200/jco.2017.77.3424
• Risk-reducing mastectomy for the prevention of primary breast cancer Cite
  Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database of Systematic Reviews. Wiley; 2018; 10.1002/14651858.cd002748.pub4
• Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study Cite
  Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, et al. Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women’s Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:1513-1520 10.1200/jco.2017.77.3424
• Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Cite
  Lammert J, Lubinski J, Gronwald J, Huzarski T, Armel S, Eisen A, et al. Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:561-571 10.1007/s10549-018-4694-1
• Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort Cite
  Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, et al. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Internal Medicine. American Medical Association (AMA); 2018; 178:494 10.1001/jamainternmed.2017.8642
• Male BRCA mutation carriers: clinical characteristics and cancer spectrum Cite
  Ibrahim M, Yadav S, Ogunleye F, Zakalik D. Male BRCA mutation carriers: clinical characteristics and cancer spectrum. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4098-y
• The frequency of missed breast cancers in women participating in a high-risk MRI screening program Cite
  Vreemann S, Gubern-Merida A, Lardenoije S, Bult P, Karssemeijer N, Pinker K, et al. The frequency of missed breast cancers in women participating in a high-risk MRI screening program. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 169:323-331 10.1007/s10549-018-4688-z
• Fertility preservation in BRCA-mutated women: when and how? Cite
  Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C. Fertility preservation in BRCA-mutated women: when and how?. Future Oncology. Future Medicine Ltd; 2018; 14:483-490 10.2217/fon-2017-0415
• Interactions of Family History of Breast Cancer with Radiotherapy in Relation to the Risk of Breast Cancer Recurrence Cite
  Li D, Mai V, Gerke T, Pinney SM, Yaghjyan L. Interactions of Family History of Breast Cancer with Radiotherapy in Relation to the Risk of Breast Cancer Recurrence. Journal of Breast Cancer. Korean Breast Cancer Society; 2017; 20:333 10.4048/jbc.2017.20.4.333
• Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study Cite
  Whitaker K, Guindalini R, Abe H, Sheeth D, Huo D, Hong S, et al. Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study. Poster Session Abstracts. American Association for Cancer Research; 2018; 10.1158/1538-7445.sabcs17-p4-02-10
• Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry Cite
  Zeinomar N, Thai A, Cloud AJ, McDonald JA, Liao Y, Terry MB. Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0189118 10.1371/journal.pone.0189118
• Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women Cite
  Walsh T, Mandell JB, Norquist BM, Casadei S, Gulsuner S, Lee MK, et al. Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women. JAMA Oncology. American Medical Association (AMA); 2017; 3:1647 10.1001/jamaoncol.2017.1996
• Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy Cite
  Fagerholm R, Faltinova M, Aaltonen K, Aittomäki K, Heikkilä P, Halttunen-Nieminen M, et al. Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy. Familial Cancer. Springer Science and Business Media LLC; 2017; 17:321-331 10.1007/s10689-017-0046-2
• CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population Cite
  Hallamies S, Pelttari LM, Poikonen-Saksela P, Jekunen A, Jukkola-Vuorinen A, Auvinen P, et al. CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population. BMC Cancer. Springer Science and Business Media LLC; 2017; 17 10.1186/s12885-017-3631-8
• Familial associations of male breast cancer with other cancers Cite
  Zheng G, Yu H, Hemminki A, Försti A, Sundquist K, Hemminki K. Familial associations of male breast cancer with other cancers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:897-902 10.1007/s10549-017-4468-1
• Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients Cite
  Sun J, Meng H, Yao L, Lv M, Bai J, Zhang J, et al. Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients. Clinical Cancer Research. American Association for Cancer Research (AACR); 2017; 23:6113-6119 10.1158/1078-0432.ccr-16-3227
• Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort Cite
  Maskarinec G, Dartois L, Delaloge S, Hopper J, Clavel-Chapelon F, Baglietto L. Tumor characteristics and family history in relation to mammographic density and breast cancer: The French E3N cohort. Cancer Epidemiology. Elsevier BV; 2017; 49:156-160 10.1016/j.canep.2017.07.003
• Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes Cite
  Parkes A, Arun BK, Litton JK. Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes. The Oncologist. Wiley; 2017; 22:655-666 10.1634/theoncologist.2016-0430
• Breast cancer phenotype in patients with hereditary gene mutations other than BRCA1 and BRCA2. Cite
  Arun B, Elsayegh N, Lin HY, Clifton K, Gutierrez-Barrera AM, Litton JK, et al. Breast cancer phenotype in patients with hereditary gene mutations other than BRCA1 and BRCA2.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:e13121-e13121 10.1200/jco.2017.35.15_suppl.e13121
• Pubertal development in girls by breast cancer family history: the LEGACY girls cohort Cite
  Terry MB, Keegan THM, Houghton LC, Goldberg M, Andrulis IL, Daly MB, et al. Pubertal development in girls by breast cancer family history: the LEGACY girls cohort. Breast Cancer Research. Springer Science and Business Media LLC; 2017; 19 10.1186/s13058-017-0849-y
• Family history and risk of breast cancer: an analysis accounting for family structure Cite
  Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 165:193-200 10.1007/s10549-017-4325-2
• Family history of breast cancer in non-BRCA male breast cancer: A case-control study. Cite
  Calip GS, Exten KR, Rauscher GH, Brown K, Bernhisel R, Kidd J, et al. Family history of breast cancer in non-BRCA male breast cancer: A case-control study.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2017; 35:e13032-e13032 10.1200/jco.2017.35.15_suppl.e13032
• Alcohol Consumption and Breast Cancer Risk in Younger Women According to Family History of Breast Cancer and Folate Intake Cite
  Kim HJ, Jung S, Eliassen AH, Chen WY, Willett WC, Cho E. Alcohol Consumption and Breast Cancer Risk in Younger Women According to Family History of Breast Cancer and Folate Intake. American Journal of Epidemiology. Oxford University Press (OUP); 2017; 186:524-531 10.1093/aje/kwx137
• Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes Cite
  Frey MK, Sandler G, Sobolev R, Kim SH, Chambers R, Bassett RY, et al. Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes. Gynecologic Oncology. Elsevier BV; 2017; 146:123-128 10.1016/j.ygyno.2017.04.009
• Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis Cite
  Song J, Chen C, Yuan J, Li J, Sun S. Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis. The Breast. Elsevier BV; 2017; 32:130-134 10.1016/j.breast.2017.01.016
• Emerging Trends in Family History of Breast Cancer and Associated Risk Cite
  Shiyanbola O, Arao R, Miglioretti D, Sprague B, Hamption J, Stout N, et al. Emerging Trends in Family History of Breast Cancer and Associated Risk. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2017; 26:438.2-438 10.1158/1055-9965.epi-17-0029
• Abstract P2-07-05: Risk of metachronous contralateral breast cancer: Systematic review and meta-analysis Cite
  Akdeniz D, Schmidt M, McCool D, van den Broek A, Hauptmann M, Seynaeve C, et al. Abstract P2-07-05: Risk of metachronous contralateral breast cancer: Systematic review and meta-analysis. Poster Session Abstracts. American Association for Cancer Research; 2017; 10.1158/1538-7445.sabcs16-p2-07-05
• The association between prognosis of breast cancer and first-degree family history of breast or ovarian cancer: a systematic review and meta-analysis Cite
  Song J, Chen C, Yuan J, Sun S. The association between prognosis of breast cancer and first-degree family history of breast or ovarian cancer: a systematic review and meta-analysis. Familial Cancer. Springer Science and Business Media LLC; 2017; 16:339-349 10.1007/s10689-017-9969-x
• Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population Cite
  Ahern TP, Sprague BL, Bissell MC, Miglioretti DL, Buist DS, Braithwaite D, et al. Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2017; 26:938-944 10.1158/1055-9965.epi-16-0801
• Tumor characteristics and prognosis in familial breast cancer Cite
  Arpino G, Pensabene M, Condello C, Ruocco R, Cerillo I, Lauria R, et al. Tumor characteristics and prognosis in familial breast cancer. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2962-1
• The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden Cite
  Sackey H, Hui M, Czene K, Verkooijen H, Edgren G, Frisell J, et al. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden. Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-016-0764-7
• Differences in survival for patients with familial and sporadic cancer Cite
  Lee M, Reilly M, Lindström LS, Czene K. Differences in survival for patients with familial and sporadic cancer. International Journal of Cancer. Wiley; 2016; 140:581-590 10.1002/ijc.30476
• Early onset breast cancer in Ashkenazi women carriers of founderBRCA1/2mutations: beyond 10 years of follow-up Cite
  Dagan E, Gershoni-Baruch R, Kurolap A, Fried G. Early onset breast cancer in Ashkenazi women carriers of founderBRCA1/2mutations: beyond 10 years of follow-up. European Journal of Cancer Care. Wiley; 2016; 26:e12594 10.1111/ecc.12594
• Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033) Cite
  Davies KR, Brewster AM, Bedrosian I, Parker PA, Crosby MA, Peterson SK, et al. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033). Breast Cancer Research. Springer Science and Business Media LLC; 2016; 18 10.1186/s13058-016-0752-y
• Earlier Age of Breast Cancer Onset in Israeli BRCA Carriers-Is it a Real Phenomenon? Cite
  Agranat S, Baris H, Kedar I, Shochat M, Rizel S, Perry S, et al. Earlier Age of Breast Cancer Onset in Israeli BRCA Carriers-Is it a Real Phenomenon?. The Breast Journal. Wiley; 2016; 22:662-666 10.1111/tbj.12653
• Abstract 2544: Association between flame-broiled fish consumption and breast cancer: A case-control study in women with high familial risk Cite
  Kaushiva A, May B, Armstrong D, Axilbund J, Visvanathan K. Abstract 2544: Association between flame-broiled fish consumption and breast cancer: A case-control study in women with high familial risk. Epidemiology. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-2544
• Paternal overweight is associated with increased breast cancer risk in daughters in a mouse model Cite
  Fontelles CC, Carney E, Clarke J, Nguyen NM, Yin C, Jin L, et al. Paternal overweight is associated with increased breast cancer risk in daughters in a mouse model. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep28602
• Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study Cite
  Moslehi R, Freedman E, Zeinomar N, Veneroso C, Levine PH. Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2369-z
• Abstract C49: Relation of family history of cancer to risk of ER+, ER-, and triple-negative breast cancer in African American women Cite
  Bethea TN, Rosenberg L, Castro-Webb N, Lunetta KL, Sucheston LE, Ruiz-Narvaez EA, et al. Abstract C49: Relation of family history of cancer to risk of ER+, ER-, and triple-negative breast cancer in African American women. Organ Site Research. American Association for Cancer Research; 2016; 10.1158/1538-7755.disp15-c49
• Abstract P6-10-17: Rates of prophylactic surgeries among BRCA 1 or 2 mutation carriers: A single institution experience Cite
  Raphael J, Hewitt P, Graham T, Ott K, Mancuso T, Lorentz J, et al. Abstract P6-10-17: Rates of prophylactic surgeries among BRCA 1 or 2 mutation carriers: A single institution experience. Poster Session Abstracts. American Association for Cancer Research; 2016; 10.1158/1538-7445.sabcs15-p6-10-17
• No strong evidence for increased risk of breast cancer 8–26 years after multiple mammograms in their 30s in females at moderate and high familial risk Cite
  Evans DG, Kotre CJ, Harkness E, Wilson M, Maxwell AJ, Howell A. No strong evidence for increased risk of breast cancer 8–26 years after multiple mammograms in their 30s in females at moderate and high familial risk. The British Journal of Radiology. British Institute of Radiology; 2016; 89:20150960 10.1259/bjr.20150960
• Family history of breast cancer and its association with disease severity and mortality Cite
  Melvin JC, Wulaningsih W, Hana Z, Purushotham AD, Pinder SE, Fentiman I, et al. Family history of breast cancer and its association with disease severity and mortality. Cancer Medicine. Wiley; 2016; 5:942-949 10.1002/cam4.648
• Survival in familial and non-familial breast cancer by age and stage at diagnosis Cite
  Kharazmi E, Försti A, Sundquist K, Hemminki K. Survival in familial and non-familial breast cancer by age and stage at diagnosis. European Journal of Cancer. Elsevier BV; 2016; 52:10-18 10.1016/j.ejca.2015.09.015
• The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer Cite
  Möller S, Mucci LA, Harris JR, Scheike T, Holst K, Halekoh U, et al. The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2015; 25:145-150 10.1158/1055-9965.epi-15-0913
• Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer Cite
  Jobsen JJ, van der Palen J, Brinkhuis M, Ong F, Struikmans H. Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer. Acta Oncologica. Informa UK Limited; 2015; 55:449-454 10.3109/0284186x.2015.1074281
• Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer? Cite
  Chikman B, Davidson T, Kais H, Jeroukhimov I, Leshno A, Sandbank J, et al. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?. Familial Cancer. Springer Science and Business Media LLC; 2015; 15:41-47 10.1007/s10689-015-9833-9
• Abstract 2747: Increasing age at first full-time pregnancy correlates to use of oral contraceptives before age 20 in women with a family history of breast cancer Cite
  Augustinsson A, Ellberg C, Kristoffersson U, Olsson H. Abstract 2747: Increasing age at first full-time pregnancy correlates to use of oral contraceptives before age 20 in women with a family history of breast cancer. Epidemiology. American Association for Cancer Research; 2015; 10.1158/1538-7445.am2015-2747
• Weight Change in Breast Cancer Survivors Compared to Cancer-Free Women: A Prospective Study in Women at Familial Risk of Breast Cancer Cite
  Gross AL, May BJ, Axilbund JE, Armstrong DK, Roden RB, Visvanathan K. Weight Change in Breast Cancer Survivors Compared to Cancer-Free Women: A Prospective Study in Women at Familial Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2015; 24:1262-1269 10.1158/1055-9965.epi-15-0212
• Background risk of breast cancer influences the association between alcohol consumption and mammographic density Cite
  Trinh T, Christensen SE, Brand JS, Cuzick J, Czene K, Sjölander A, et al. Background risk of breast cancer influences the association between alcohol consumption and mammographic density. British Journal of Cancer. Springer Science and Business Media LLC; 2015; 113:159-165 10.1038/bjc.2015.185
• Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis Cite
  van den Broek AJ, Schmidt MK, van ‘t Veer LJ, Tollenaar RAEM, van Leeuwen FE. Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0120189 10.1371/journal.pone.0120189
• Lobular breast cancer: incidence and genetic and non-genetic risk factors Cite
  Dossus L, Benusiglio PR. Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Research. Springer Science and Business Media LLC; 2015; 17 10.1186/s13058-015-0546-7
• Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients Cite
  Bick U. Intensified Surveillance for Early Detection of Breast Cancer in High-Risk Patients. Breast Care. S. Karger AG; 2015; 10:13-20 10.1159/000375390
• Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study Cite
  Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, et al. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer. Wiley; 2015; 121:1265-1272 10.1002/cncr.29075
• Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program Cite
  Castells X, Domingo L, Corominas JM, Torá-Rocamora I, Quintana MJ, Baré M, et al. Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 149:237-244 10.1007/s10549-014-3208-z
• Evolution of Genetic Testing for Inherited Susceptibility to Breast Cancer Cite
  Domchek SM. Evolution of Genetic Testing for Inherited Susceptibility to Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:295-296 10.1200/jco.2014.59.3178
• Contribution of shared environmental factors to familial aggregation of common cancers Cite
  Sundquist K, Sundquist J, Ji J. Contribution of shared environmental factors to familial aggregation of common cancers. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2015; 24:162-164 10.1097/cej.0000000000000101
• Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less Cite
  Bayraktar S, Amendola L, Gutierrez-Barrera AM, Hashmi SS, Amos C, Gambello M, et al. Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less. The Breast. Elsevier BV; 2014; 23:770-774 10.1016/j.breast.2014.08.010
• Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control study Cite
  Zhou W, Ding Q, Pan H, Wu N, Liang M, Huang Y, et al. Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control study. BMC Cancer. Springer Science and Business Media LLC; 2014; 14 10.1186/1471-2407-14-662
• Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer Cite
  Lindström L, Li J, Lee M, Einbeigi Z, Hartman M, Hall P, et al. Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer. Annals of Oncology. Elsevier BV; 2014; 25:1966-1972 10.1093/annonc/mdu270
• Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: A nationwide family study Cite
  Zöller B, Li X, Sundquist J, Sundquist K. Familial transmission of prostate, breast and colorectal cancer in adoptees is related to cancer in biological but not in adoptive parents: A nationwide family study. European Journal of Cancer. Elsevier BV; 2014; 50:2319-2327 10.1016/j.ejca.2014.05.018
• Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast Cite
  Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, et al. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast. PLoS Genetics. Public Library of Science (PLoS); 2014; 10:e1004285 10.1371/journal.pgen.1004285
• A Clinicopathological Study of Early-Stage Synchronous Bilateral Breast Cancer: A Retrospective Evaluation and Prospective Validation of Potential Risk Factors Cite
  Chen J, Wang Y, Xue J, Chen Y, Chen Y, Xiao Q, et al. A Clinicopathological Study of Early-Stage Synchronous Bilateral Breast Cancer: A Retrospective Evaluation and Prospective Validation of Potential Risk Factors. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e95185 10.1371/journal.pone.0095185
• Cigarette Smoking, Physical Activity, and Alcohol Consumption as Predictors of Cancer Incidence among Women at High Risk of Breast Cancer in the NSABP P-1 Trial Cite
  Land SR, Liu Q, Wickerham DL, Costantino JP, Ganz PA. Cigarette Smoking, Physical Activity, and Alcohol Consumption as Predictors of Cancer Incidence among Women at High Risk of Breast Cancer in the NSABP P-1 Trial. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2014; 23:823-832 10.1158/1055-9965.epi-13-1105-t
• Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status Cite
  Nilsson MP, Hartman L, Idvall I, Kristoffersson U, Johannsson OT, Loman N. Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 144:133-142 10.1007/s10549-014-2842-9
• Family history of cancer and the risk of cancer: a network of case–control studies Cite
  Turati F, Edefonti V, Bosetti C, Ferraroni M, Malvezzi M, Franceschi S, et al. Family history of cancer and the risk of cancer: a network of case–control studies. Annals of Oncology. Elsevier BV; 2013; 24:2651-2656 10.1093/annonc/mdt280
• BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer Cite
  SAMBIASI D, LAMBO R, PILATO B, TOMMASI S, TROJANO G, KARDHASHI A, et al. BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer. Oncology Reports. Spandidos Publications; 2013; 31:365-369 10.3892/or.2013.2802
• Can Unknown Predisposition in Familial Breast Cancer be Family-Specific? Cite
  Lynch H, Wen H, Kim YC, Snyder C, Kinarsky Y, Chen PX, et al. Can Unknown Predisposition in Familial Breast Cancer be Family-Specific?. The Breast Journal. Wiley; 2013;:n/a-n/a 10.1111/tbj.12145
• Differences in Mammographic Density Decline over Time in Breast Cancer Cases and Women at High Risk for Breast Cancer Cite
  ME W, LL R, AS Q, KD C, A W, MB T. Differences in Mammographic Density Decline over Time in Breast Cancer Cases and Women at High Risk for Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2013; 22:476.1-476 10.1158/1055-9965.epi-13-0078
• Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation Cite
  Rinella ES, Shao Y, Yackowski L, Pramanik S, Oratz R, Schnabel F, et al. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Human Genetics. Springer Science and Business Media LLC; 2013; 132:523-536 10.1007/s00439-013-1269-4
• Risk of Asynchronous Contralateral Breast Cancer in Noncarriers of BRCA1 and BRCA2 Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study Cite
  Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, et al. Risk of Asynchronous Contralateral Breast Cancer in Noncarriers of BRCA1 and BRCA2 Mutations With a Family History of Breast Cancer: A Report From the Women's Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2013; 31:433-439 10.1200/jco.2012.43.2013
• Familial risk of early and late onset cancer: nationwide prospective cohort study Cite
  Kharazmi E, Fallah M, Sundquist K, Hemminki K. Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ. BMJ; 2012; 345:e8076-e8076 10.1136/bmj.e8076
• Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer Cite
  Pern F, Bogdanova N, Schürmann P, Lin M, Ay A, Länger F, et al. Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e47993 10.1371/journal.pone.0047993
• Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK) Cite
  Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Nogues C, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ. BMJ; 2012; 345:e5660-e5660 10.1136/bmj.e5660
• Genetic variants associated with breast size also influence breast cancer risk Cite
  Eriksson N, Benton GM, Do CB, Kiefer AK, Mountain JL, Hinds DA, et al. Genetic variants associated with breast size also influence breast cancer risk. BMC Medical Genetics. Springer Science and Business Media LLC; 2012; 13 10.1186/1471-2350-13-53
• Timing of Familial Breast Cancer in Sisters Cite
  Rebora P, Czene K, Reilly M. Timing of Familial Breast Cancer in Sisters. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2008; 100:721-727 10.1093/jnci/djn146
• Family history and risk of breast cancer: nurses’ health study Cite
  Colditz GA, Kaphingst KA, Hankinson SE, Rosner B. Family history and risk of breast cancer: nurses’ health study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 133:1097-1104 10.1007/s10549-012-1985-9
• Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort Cite
  Yaghjyan L, Mahoney MC, Succop P, Wones R, Buckholz J, Pinney SM. Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. British Journal of Cancer. Springer Science and Business Media LLC; 2012; 106:996-1003 10.1038/bjc.2012.1
• Impact of X Chromosome Genes in Explaining the Excess Risk of Cancer in Males Cite
  Biggar RJ, Bergen AW, Poulsen GN. Impact of X Chromosome Genes in Explaining the Excess Risk of Cancer in Males. American Journal of Epidemiology. Oxford University Press (OUP); 2009; 170:65-71 10.1093/aje/kwp083
• P2-13-02: Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis. Cite
  Shapira I, Budman D, Akerman M, Weiselberg L, Vinciguerra V, D'Olimpio J, et al. P2-13-02: Parent of Origin of BRCA Mutation May Determine Age at Breast Cancer Diagnosis.. Poster Session Abstracts. American Association for Cancer Research; 2011; 10.1158/0008-5472.sabcs11-p2-13-02
• Risk of breast cancer in families of multiple affected women and men Cite
  Bevier M, Sundquist K, Hemminki K. Risk of breast cancer in families of multiple affected women and men. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:723-728 10.1007/s10549-011-1915-2
• Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers? Cite
  Bernholtz S, Laitman Y, Kaufman B, Shimon-Paluch S, Friedman E. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:669-673 10.1007/s10549-011-1886-3
• Young women with family history of breast cancer and their risk factors for benign breast disease Cite
  Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. Wiley; 2011; 118:2796-2803 10.1002/cncr.26519
• Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry Cite
  Kurian AW, Gong GD, John EM, Johnston DA, Felberg A, West DW, et al. Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:4505-4509 10.1200/jco.2010.34.4440
• High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients Cite
  Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, et al. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. International Journal of Cancer. Wiley; 2012; 131:1114-1123 10.1002/ijc.27326
• Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers Cite
  Bernholtz S, Jakobson-Setton A, Korach J, Ben Baruch G, Laitman Y, Friedman E. Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 131:981-985 10.1007/s10549-011-1807-5
• Earlier age of onset ofBRCAmutation-related cancers in subsequent generations Cite
  Litton JK, Ready K, Chen H, Gutierrez-Barrera A, Etzel CJ, Meric-Bernstam F, et al. Earlier age of onset ofBRCAmutation-related cancers in subsequent generations. Cancer. Wiley; 2011; 118:321-325 10.1002/cncr.26284
• Does maternal or paternal inheritance of BRCA mutation affect the age of cancer diagnosis? Cite
  Shapira I, Gralla RJ, Akerman M, Weiselberg LR, John VS, Raftopoulos H, et al. Does maternal or paternal inheritance of BRCA mutation affect the age of cancer diagnosis?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:1510-1510 10.1200/jco.2011.29.15_suppl.1510
• Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics Cite
  Verkooijen HM, Hartman M, Usel M, Benhamou S, Neyroud-Caspar I, Czene K, et al. Breast cancer prognosis is inherited independently of patient, tumor and treatment characteristics. International Journal of Cancer. Wiley; 2011; 130:2103-2110 10.1002/ijc.26206
• Prospective study of growth and development in older girls and risk of benign breast disease in young women Cite
  Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Colditz GA. Prospective study of growth and development in older girls and risk of benign breast disease in young women. Cancer. Wiley; 2011; 117:1612-1620 10.1002/cncr.25692
• Familial Mortality and Familial Incidence in Cancer Cite
  Hemminki K, Sundquist J, Brandt A. Familial Mortality and Familial Incidence in Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:712-718 10.1200/jco.2010.30.5664
• Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study Cite
  Gramling R, Lash TL, Rothman KJ, Cabral HJ, Silliman R, Roberts M, et al. Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study. Breast Cancer Research. Springer Science and Business Media LLC; 2010; 12 10.1186/bcr2727
• A cluster of inflammatory breast cancer (IBC) in an office setting: Additional evidence of the importance of environmental factors in IBC etiology Cite
  Levine . A cluster of inflammatory breast cancer (IBC) in an office setting: Additional evidence of the importance of environmental factors in IBC etiology. Oncology Reports. Spandidos Publications; 2010; 24 10.3892/or_00000983
• Risk of second breast cancer according to estrogen receptor status and family history Cite
  Bouchardy C, Benhamou S, Fioretta G, Verkooijen HM, Chappuis PO, Neyroud-Caspar I, et al. Risk of second breast cancer according to estrogen receptor status and family history. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 127:233-241 10.1007/s10549-010-1137-z
• Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations Cite
  Dite GS, Whittemore AS, Knight JA, John EM, Milne RL, Andrulis IL, et al. Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. British Journal of Cancer. Springer Science and Business Media LLC; 2010; 103:1103-1108 10.1038/sj.bjc.6605876
• Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk Cite
  Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, et al. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 126:671-678 10.1007/s10549-010-1148-9
• Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer Cite
  Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:863-873 10.1007/s10549-010-1106-6
• Risk of breast cancer in male BRCA2 carriers Cite
  Evans DGR, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F. Risk of breast cancer in male BRCA2 carriers. Journal of Medical Genetics. BMJ; 2010; 47:710-711 10.1136/jmg.2009.075176
• Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer Cite
  Ellberg C, Olsson H. Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer. BMC Cancer. Springer Science and Business Media LLC; 2011; 11 10.1186/1471-2407-11-497
• Characterizing benign breast disease in women at high risk for breast cancer. Cite
  Israel SA, Nassar H, Gross AL, Jacobs LK, Armstrong DK, Visvanathan K. Characterizing benign breast disease in women at high risk for breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1506-1506 10.1200/jco.2010.28.15_suppl.1506
• 500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival? Cite
  Heemskerk-Gerritsen B, Hooning M, Jager A, Tilanus-Linthorst M, Bartels C, van den Ouweland A, et al. 500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:206 10.1016/s1359-6349(10)70521-8
• Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age Cite
  van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJE, de Vries J, et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:643-651 10.1007/s10549-010-0805-3
• Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial Cite
  Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, König R, et al. Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:1450-1457 10.1200/jco.2009.23.0839
• Some characteristics of familial breast cancer Cite
  Anderson DE. Some characteristics of familial breast cancer. Cancer. Wiley; 1971; 28:1500-1504 10.1002/1097-0142(197112)28:6<1500::aid-cncr2820280623>3.0.co;2-d
• Risk Factors for Male Breast Cancer?A Case-Control Study from Scandinavia Cite
  Marianne Ewertz LH. Risk Factors for Male Breast Cancer?A Case-Control Study from Scandinavia. Acta Oncologica. Informa UK Limited; 2001; 40:467-471 10.1080/02841860117406
• 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis Cite
  Jansen-van der Weide M, Greuter M, Jansen L, Oosterwijk J, Pijnappel R, Oudkerk M, et al. 622 Mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition: a meta-analysis. European Journal of Cancer Supplements. Elsevier BV; 2010; 8:239 10.1016/s1359-6349(10)70642-x
• Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening Cite
  Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, et al. Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. Journal of Medical Genetics. BMJ; 2006; 44:10-15 10.1136/jmg.2006.043091
• Risk Factors for Breast Cancer at Young Ages in Twins: An International Population-Based Study Cite
  Swerdlow AJ. Risk Factors for Breast Cancer at Young Ages in Twins: An International Population-Based Study. CancerSpectrum Knowledge Environment. Oxford University Press (OUP); 2002; 94:1238-1246 10.1093/jnci/94.16.1238
• Dietary intake and breast density in high-risk women: a cross-sectional study Cite
  Tseng M, Byrne C, Evers KA, Daly MB. Dietary intake and breast density in high-risk women: a cross-sectional study. Breast Cancer Research. Springer Science and Business Media LLC; 2007; 9 10.1186/bcr1781
• Lactation and Incidence of Premenopausal Breast Cancer Cite
  Stuebe AM, Willett WC, Xue F, Michels KB. Lactation and Incidence of Premenopausal Breast Cancer. Archives of Internal Medicine. American Medical Association (AMA); 2009; 169:1364 10.1001/archinternmed.2009.231
• Age of onset in familial breast cancer as background data for medical surveillance Cite
  Brandt A, Bermejo JL, Sundquist J, Hemminki K. Age of onset in familial breast cancer as background data for medical surveillance. British Journal of Cancer. Springer Science and Business Media LLC; 2009; 102:42-47 10.1038/sj.bjc.6605421
• Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status: The Multiethnic Cohort Study Cite
  Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status: The Multiethnic Cohort Study. American Journal of Epidemiology. Oxford University Press (OUP); 2009; 169:1251-1259 10.1093/aje/kwp036
• Alcohol intake and breast cancer risk among young women Cite
  Berstad P, Ma H, Bernstein L, Ursin G. Alcohol intake and breast cancer risk among young women. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2007; 108:113-120 10.1007/s10549-007-9578-8